The first study quantifying the global costs of sloth was published Thursday in the scientific journal The Lancet, finding what researchers labeled a conservative estimate of the economic burden caused by inactivity.
More than 40 percent of that total, $27.8 billion, is attributed to the U.S., illustrating a gap between high- and low-income countries. Lower- and middle-income countries shared 75 percent of the disease burden but less than 20 percent of the economic burden, said Melody Ding, lead author of the study and a senior research fellow at the University of Sydney’s school of public health.
“The most striking finding is not the actual number, it’s the distribution of the economic burden across regions,” Ding said. “In wealthy countries, people pay with their pockets. In less wealthy countries, they’re paying with their lives.”
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
